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Left ventricular noncompaction (LVNC) is associated with heart failure and arrhythmias, such as atrioventricular block 
and intraventricular conduction disturbance. Recently, we have 
demonstrated that genetic defects of the LIM domain-binding 
protein 3–encoding Z-band alternatively spliced PDZ-motif 
 protein (ZASP) are associated with LVNC.1 In the study, we iden-
tified ZASP1-D117N mutation in 2 white men who suffered from 
systolic dysfunction, dilated left ventricle with hypertrabeculated 
myocardium, and intraventricular conduction disturbance. Both 
patients showed sporadic heterozygote mutation. One of the 
patients had a family history of sudden cardiac death.
Clinical Perspective on p 1026
ZASP is one of the major components of the Z-disk pro-
teins in cardiac muscle,2 which plays an important role in 
stabilizing the Z-disk structure through its PDZ-mediated 
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Background—Defects of cytoarchitectural proteins can cause left ventricular noncompaction, which is often associated 
with conduction system diseases. We have previously identified a p.D117N mutation in the LIM domain-binding protein 
3–encoding Z-band alternatively spliced PDZ motif gene (ZASP) in a patient with left ventricular noncompaction and 
conduction disturbances. We sought to investigate the role of p.D117N mutation in the LBD3 NM_001080114.1 isoform 
(ZASP1-D117N) for the regulation of cardiac sodium channel (Na
v
1.5) that plays an important role in the cardiac 
conduction system.
Methods and Results—Effects of ZASP1-wild-type and ZASP1-D117N on Na
v
1.5 were studied in human embryonic 
kidney-293 cells and neonatal rat cardiomyocytes. Patch-clamp study demonstrated that ZASP1-D117N significantly 
attenuated INa by 27% in human embryonic kidney-293 cells and by 32% in neonatal rat cardiomyocytes. In addition, 
ZASP1-D117N rightward shifted the voltage-dependent activation and inactivation in both systems. In silico simulation 
using Luo-Rudy phase 1 model demonstrated that altered Na
v
1.5 function can reduce cardiac conduction velocity by 28% 
compared with control. Pull-down assays showed that both wild-type and ZASP1-D117N can complex with Na
v
1.5 and 
telethonin/T-Cap, which required intact PDZ domains. Immunohistochemical staining in neonatal rat cardiomyocytes 
demonstrates that ZASP1-D117N did not significantly disturb the Z-line structure. Disruption of cytoskeletal networks 
with 5-iodonaphthalene-1-sulfonyl homopiperazine and cytochalasin D abolished the effects of ZASP1-D117N on Na
v
1.5.
Conclusions—ZASP1 can form protein complex with telethonin/T-Cap and Na
v
1.5. The left ventricular noncompaction-
specific ZASP1 mutation can cause loss of function of Na
v
1.5, without significant alteration of the cytoskeletal protein 
complex. Our study suggests that electric remodeling can occur in left ventricular noncompaction subject because of a 
direct effect of mutant ZASP on Na
v
1.5. (Circ Arrhythm Electrophysiol. 2012;5:1017-1026.)
Key Words: Z-band alternatively spliced PDZ motif gene ◼ sodium channel ◼ cardiac conduction disturbance  
◼ left ventricular noncompaction
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interaction with α-actinin-2, the main component of the 
Z-disk actin cross-linker, and F-actin, the main cytoarchi-
tectural protein of cardiomyocytes.3 Global ablation of the 
murine ZASP homolog cypher can disorganize both sarco-
mere and cytoskeleton, leading to severe cardiomyopathy and 
skeletal myopathy in mice and humans, termed zaspopathy,4 
whereas the cardiac-specific ablation of cypher led to dilated 
cardiomyopathy and sudden cardiac death.5 However, the 
detailed underlying mechanisms of arrhythmias in zaspopa-
thy remain unclear.
In contrast, loss of function of sodium channel (Na
v
1.5) 
has been recognized as a key pathophysiological mecha-
nism of inherited conduction diseases.6 In addition, recent 
studies proposed a novel concept that the defects of nonion 
channel proteins or channel-interacting proteins can affect 
the function of various ion channels, leading to secondary 
channelopathies.7–10
Along these lines of evidence, we hypothesized that mutant 
ZASP in LVNC patients might affect Na
v
1.5. The effects 
of ZASP1-D117N on the function of Na
v
1.5 and the ana-
tomic remodeling of cytoarchitecture were studied in mam-
malian expression systems and neonatal rat cardiomyocytes 
(NRCMs). The amplitude and voltage dependency of acti-
vation and inactivation of Na
v
1.5 were affected by ZASP1-
D117N, which can lead to conduction disturbances confirmed 
by a computer simulation. These findings uncover some key 
elements of the mechanisms leading to conduction distur-
bances in zaspopathy.
Materials and Methods
Human Embryonic Kidney-293 Cell Preparation and 
Transient Expression of Wild-type and Mutant ZASP1
The detail methods are described in Expanded Methods in the on-
line-only Data Supplement. Briefly, human embryonic kidney-293 
(HEK-293) cells stably expressing hNa
v
1.5 were transfected with the 
plasmid pcDNA3.1–CT-green fluorescent protein-TOPO containing 
wild-type (wt) or mutant ZASP1 cDNA.
NRCM Isolation and Transient Expression of wt 
and Mutant ZASP1
This research protocol was approved by the Institutional Animal Care 
and Use Committee at Texas Heart Institute and Indiana University. 
The NRCMs were isolated according to the  procedure described previ-
ously (see Expanded Methods in the online-only Data Supplement).10
Patch Clamp
Whole-cell configuration of the voltage-clamp technique was used to 
record INa and IK as previously described (see Expanded Methods in 
the online-only Data Supplement).10
Computer Simulation
Computer simulations of conduction were performed in a 3-cm-
long cable of coupled myocytes described by the Luo-Rudy phase 1 
model.11 The voltage is governed by the following partial differential 
equation:
¶
¶
¶
¶
V
t
I
C
D V
t
= - +ion
m
2
2
where C
m
=1 μF/cm2, and D=0.001 cm2/ms is the diffusion  constant. 
This value of the diffusion constant corresponds to a lumped 
myoplasmic and gap junctional intercellular conductance of 0.92 
μS.12 The differential equations were integrated with a finite differ-
ence method, with a spatial step of 100 μm and a time step of 0.01 
ms. The maximum sodium channel conductance was set as GNa=16 
mS/cm2, which gives rise to a conduction velocity (CV) of 57.4 cm/s.
Immunohistochemistry
Immunohistochemical staining was performed by the standard tech-
nique as described in Expanded Methods in the online-only Data 
Supplement.
In Vitro Interaction Pull-Down Assay
Interactions between ZASP1 and Na
v
1.5 were studied with His-tagged 
pull-down assays (ProFound pull-down PolyHis Protein:Protein 
Interaction Kit; Pierce, IL; see details in Expanded Methods in the 
online-only Data Supplement).
Statistics
Comparison of the continuous variables between 2 groups (ZASP1-
wt versus ZASP1-D117N) was performed using Mann-Whitney-
Wilcoxon test. The Kruskal-Wallis test was conducted to compare 
continuous variables among 3 groups, with post hoc Mann-Whitney-
Wilcoxon test to compare differences between any 2 groups. All 
comparisons were performed to test 2-tailed methods, and P<0.05 
was considered statistically significant. Statistical analyses were per-
formed using SPSS PASW Statistics 17 software (IBM, Chicago, IL). 
Data in the text and figures are presented as median (25th percentile; 
75th percentile) or mean±SD unless otherwise stated.
Results
ZASP1-D117N Causes Loss of Function of hNa
v
1.5 
in HEK-293 Cells
To study the effects of wt and mutant ZASP1 on hNa
v
1.5 func-
tion, HEK-293 cells stably expressing hNa
v
1.5 were transiently 
transfected with green fluorescent protein-tagged ZASP1-wt or 
ZASP1-D117N plasmids (5 μg). Figure 1A represents superim-
posed macroscopic hNa
v
1.5 current (INa) traces at various depo-
larization levels obtained from the cells expressing ZASP1-wt 
or ZASP1-D117N. The peak INa densities were significantly 
reduced in the cells transfected with ZASP1-D117N compared 
with ZASP1-wt. Compared with ZASP1-wt, ZASP1-D117N 
shifted the onset and peak voltage of the I-V curve toward posi-
tive by 10 and 15 mV, respectively (Figure 1B).
To study the voltage dependency of steady-state activa-
tion and inactivation, the peak conductance and peak cur-
rents induced by a prepulse protocol were plotted against the 
membrane potentials and fitted with the Boltzman equation. 
ZASP1-D117N was found to rightward shift the activation 
curve by 7 mV and rightward shift the inactivation curve 
by 5 mV compared with ZASP1-wt (Figure 1C). The slope 
factors (k) in the steady-state activation were also affected 
by ZASP1-D117N. Despite the smaller shift of inactivation 
curve, the larger shift of activation curve might increase the 
voltage threshold required to activate INa, contributing to the 
decrease in CV.13
Recovery time course from fast inactivation was exam-
ined by a double-pulse protocol. ZASP1-D117N was found 
to accelerate the fast component of recovery time compared 
with ZASP1-wt (Figure 1D). Figure 1E represents the devel-
opment of slow inactivation. The time course was compara-
ble between the 2 groups. In addition, direct transition from 
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closed state to inactivation state without channel opening 
(closed-state inactivation) was studied. Interestingly, the time 
course of closed-state inactivation was accelerated by ZASP1-
D117N compared with ZASP1-wt (Figure 1F). Tables 1 and 
2 summarize the parameters of INa studied in HEK-293 cells.
The effects of ZASP1-D117N on the late INa were also stud-
ied in HEK-293 cells. ZASP1-D117N did not significantly 
affect the 30-μmol/L tetrodotoxin-sensitive late INa induced 
by a long depolarization pulse (online-only Data Supplement 
Figure I).
Figure 1. The effects of ZASP1-wt and ZASP1-D117N on hNav1.5 in HEK-293 cells. A, Superimposed whole-cell current traces induced 
by a step-pulse protocol (20 ms between –120 and 80 mV) from a holding potential of –140 mV. B, I-V relationships. C, Voltage depen-
dence of peak conductance and steady-state fast inactivation. Conductance G(V) was calculated by the equation G(V)=I/(Vm–Erev), where 
I is the peak current, Erev is the measured reversal potential, and Vm is the membrane potential. The normalized peak conductance was 
plotted as a function of membrane potentials. Steady-state inactivation was estimated by prepulse protocols (500 ms) from a holding 
potential of –140 mV. The normalized peak currents were plotted as a function of membrane potentials. Steady-state activation and inac-
tivation were fitted with the Boltzmann equation y=(1+exp [Vh–Vm]/k)
–1, where y represents variables; Vh, midpoint; k, slope factor; and Vm, 
membrane potential. Data were represented as mean±SD. D, Recovery from the fast inactivation estimated by a double-pulse protocol 
shown in inset. The recovery time course was fitted with a double exponential function I(t)/Imax=C–Af ×exp (–t/τf)–As×exp (−t/τs), where t is 
the recovery time, Af and As are the fraction of fast and slow components, and τf and τs are the time constants of fast and slow compo-
nents of recovery. E, Time course for the development of slow inactivation. The pulse protocol is shown as inset. Voltage was stepped 
from a holding potential of –90 to –30 mV for various times, stepped to –90 mV for 20 ms to allow recovery from fast inactivation, and 
then stepped to –30 mV (20 ms). To generate the curves, the current amplitude during the test pulse (second pulse) was normalized as a 
fraction of the current amplitude during the first pulse and plotted against the duration of control pulse. The curve was fit with a double 
exponential equation. F, Closed-state inactivation. The membrane potential was held at –100 mV for various durations (Δt) from a hold-
ing potential of –140 mV before the test pulse (20 ms at –20 mV). The normalized currents by the maximal currents (t=1 ms) were plotted 
against Δt. Data are presented as mean±SD.
Table 1. Nav1.5 Parameters
HEK-293 Cells NRCMs
wt (n) D117N (n) wt (n) D117N (n)
Peak current density, pA/pF 20
−265.1 (−306.4 to −181.8)
19
−142. 2 (−207.0 to −82.7)*
16
−756.8 (−1079.6 to −545.5)
13
−650.0 (−701.8 to −576.0)
Activation 23 18 19 11
Vh, mV −45.4 (−52.2 to −41.3) −36.7 (−43.8 to −30.3)† −46.8 (−51.6 to −38.8) −32.1 (−39.4 to −30.8)†
k 7.26 (5.9 to 8.4) 6.55 (5.8 to 8.1)* 7.3 (6.4 to 7.7) 7.4 (7.1 to 7.9)
Fast inactivation 16 19 16 8
Vh, mV −97.0 (−103.0 to −95.4) −92.8 (−98.1 to −90.9)† −95.7 (−101.9 to −92.1) −85.7 (−99.9 to −77.6)†
k 6.1 (5.8 to 6.5) 7.2 (6.4 to 7.8) 6.9 (6.1 to 7.4) 7.5 (6.7 to 7.8)
NRCM indicates neonatal rat cardiomyocytes; n, the number of patches; Vh, midpoint voltage of maximal activation/inactivation; k, slope factor.
*P<0.05; †P<0.01 vs ZASP1-wt.
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Because our patients were heterozygote,1 we also stud-
ied the effects of different ratios of ZASP1-wt and ZASP1-
D117N plasmids on INa. Although transfection with 5 μg of 
ZASP1-wt and 1 μg of ZASP1-D117N plasmids did not sig-
nificantly reduce INa compared with 5 μg of ZASP1-wt, the 
transfection with 3 μg of ZASP1-wt and 3 μg of ZASP1-
D117N, which might mimic the heterozygotic situation, 
significantly decreased INa and rightward shifted the peak volt-
age (online-only Data Supplement Figure II).
Effects of ZASP1-D117N on Delayed Rectifier 
Potassium Channels
We also studied whether ZASP1-D117N can affect 2 major 
components of delayed rectifier potassium channels (slow 
component, IKs and rapid component, IKr). ZASP1-D117N 
did not significantly affect IKs and IKr in mammalian cell 
lines (online-only Data Supplement Figure III). These results 
indicate that ZASP1-D117N specifically alters the Na
v
1.5 
functions.
Expression of ZASP1 and Cytoarchitectural 
Proteins in HEK-293 Cells
The expression of mRNAs from genes encoding various 
cytoarchitectural proteins in HEK-293 cells suggests that 
this cell line may express cardiomyocyte-like proteins.14 The 
expression of various cytoskeletal proteins was studied using 
proteins extracted from HEK-293 cells stably expressing 
Flag-tagged hNa
v
1.5 and transiently expressing V5-tagged 
ZASP1-wt or ZASP1-D117N. Figure 2 demonstrates that 
exogenous ZASP1-wt and ZASP1-D117N (V5-tagged), as 
well as endogenous ZASP, α-actinin-2, dystrophin (DMD), 
syntrophin α1, T-Cap, and β-actin, were expressed in HEK-
293 cells.
Protein Interaction Between Na
v
1.5 and  
ZASP1-Telethonin/T-Cap Complex
To study the protein-protein interaction between hNa
v
1.5 
and ZASP1-wt or ZASP1-D117N, pull-down assays were 
performed (Figure 3). First, 3 batches of Escherichia coli 
were transformed with the plasmids containing SCN5A, V5/
His-tagged ZASP1-wt, or V5/His-tagged ZASP1-D117N. The 
protein expression of Na
v
1.5 and ZASP was confirmed with 
Western blot using anti-pan sodium channel and anti-V5 anti-
bodies (panel A, left blot). Second, the proteins extracted from 
the HEK-293 cells stably expressing hNa
v
1.5 were incubated 
with V5/His-tagged ZASP1-wt or ZASP1-D117N produced in 
E. coli transformed with the corresponding plasmids. The pro-
tein mixture was immunoprecipitated with the beads coated 
with anti-His antibody. The precipitants were analyzed with 
Western blot using anti-pan sodium channel antibody, anti–T-
Cap antibody, and anti-V5 antibody. The results showed that 
both ZASP1-wt and ZASP1-D117N can form a protein com-
plex with hNa
v
1.5 and T-Cap (panel A, mid blot). Third, the 
same protocol was performed using the NRCM lysates. Panel 
A, right blot shows that both ZASP1-wt and ZASP1-D117N 
can form a protein complex with rat Na
v
1.5 and T-Cap.
Because ZASP1 possesses N-terminal PDZ domain that 
is important for protein-protein interaction, we examined 
whether the PDZ domain is essential for the formation of 
protein complex. A pull-down assay using a ZASP1 segment 
(ZM) that lacks the PDZ domain was performed. The proteins 
extracted from the stable HEK-293 cells were incubated with 
V5/His-tagged ZM-wt or ZM-D117N produced in E. coli. The 
protein mixture was immunoprecipitated with anti-His anti-
body, and the precipitants were analyzed with Western blot. 
Figure 3B shows that neither Na
v
1.5 nor T-Cap was detected 
in the immunoprecipitants, indicating that the PDZ domain is 
critically involved in the formation of protein complex among 
ZASP1, Na
v
1.5, and T-Cap.
ZASP1-D117N Alters Na
v
1.5 Functions in NRCMs
The interaction and functional modification of INa by ZASP in 
HEK-293 cells may substantially differ from those in cardio-
myocytes. Therefore, we studied the effects of ZASP1-wt and 
ZASP1-D117N on INa in NRCMs. The isolated NRCMs were 
transfected with green fluorescent protein-tagged ZASP1-
wt or ZASP1-D117N using electroporation. Figure 4A rep-
resents superimposed macroscopic INa traces obtained from 
the NRCMs transfected with ZASP1-wt or ZASP1-D117N. 
Similar to the observation in HEK-293 cells, ZASP1-D117N 
decreased the INa densities and rightward shifted the onset and 
peak voltage of I-V relationships by 15 mV compared with 
ZASP1-wt (Figure 4B). ZASP1-D117N was found to right-
ward shift the voltage dependency of steady-state activation 
and inactivation by 11.8 and 8.4 mV, respectively (Figure 4C). 
The slope factors in the steady-state activation and inactiva-
tion were not significantly affected by ZASP1-D117N (Figure 
4C). These data indicate that ZASP1-D117N can cause loss 
of function of cardiac sodium channel in NRCMs similar to 
the effects on human Na
v
1.5 in mammalian cell lines. Table 1 
summarizes the INa parameters in NRCMs.
Localization of ZASP1 and Cytoarchitectural 
Proteins in NRCMs
Next, we studied the localization of ZASP-wt and ZASP-
D117N in NRCMs. NRCMs were transfected with green 
fluorescent protein-tagged ZASP1-wt or ZASP1-D117N. The 
cells were cultured for 24 to 48 hours, then fixed and stained 
with antibodies against various cytoarchitectural proteins. The 
Table 2. Time-Dependent Parameters of Nav1.5
wt (n) D117N (n)
Recovery from fast 
inactivation
10 8
τf, ms 4.2 (3.2–5.2) 1.9 (1.8–2.2)
τs, ms 24.6 (22.2–27.0) 54.0 (42.1–61.1)*
Af, % 0.3 (0.2–0.3) 0.1 (0.1–0.2)*
As, % 0.9 (0.8–0.9) 0.9 (0.9–1.1)
Closed-state inactivation 14 19
τ, ms 68.2 (50.4–80.9) 81.8 (72.0–113.4)*
Slow inactivation 8 8
τ, ms 800.1 (761.4–838.8) 1202.6 (1145.5–1347.0)
n indicates the number of patches; τf and τs, the time constants of fast 
and slow components of recovery; Af and As, the fraction of fast and slow 
components.
*P<0.05 vs ZASP1-wt.
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fluorescence confocal images demonstrated that both ZASP1-
wt and ZASP1-D117N exist along the Z-lines and were clearly 
overlapped with the Z-disk proteins (ie, α-actinin-2, T-Cap, and 
actin; top and bottom panels in Figure 5). In contrast, DMD and 
syntrophin α1 showed less clear overlap with ZASP compared 
with Z-disk proteins (second and third panels in Figure 5). 
These data suggest that ZASP1-D117N can affect INa without 
significant disruption of the Z-disk protein complex in NRCMs.
Disruption of Actin Abolished the Alteration  
of Na
v
1.5 Function by ZASP1-D117N
Next, we used 5-iodonaphthalene-1-sulfonyl homopipera-
zine (ML-7) a highly specific inhibitor of myosin light chain 
kinase, and cytochalasin D, a potent inhibitor of actin polym-
erization (Cyto-D). Both reagents are known to disrupt cyto-
skeletal structures mainly by disassembling actin fibers that 
are important members of Z-line structure.15,16
The NRCMs transiently transfected with green fluorescent 
protein-tagged ZASP1-wt or ZASP1-D117N were incubated 
with ML-7 (30 μmol/L) or Cyto-D (2 μmol/L) for 30 minutes 
before patch-clamp experiments. Interestingly, the reduction 
of INa and the shift of I-V curves by ZASP1-D117N were abol-
ished with these treatments (Figure 6A and 6B). Figure 6C 
demonstrates that the voltage dependency of steady-state acti-
vation and inactivation was not affected by ZASP1-D117N 
after ML-7 treatment. Similar results were obtained in the 
cells treated with Cyto-D (Figure 6D–6F). Table 3 summa-
rizes the parameters with ML-7 and Cyto-D treatments.
Decline of Na+ Conductance by ZASP1-D117N 
Modulates CV and Conduction Failure
An important question is whether these modifications of Na
v
1.5 
by ZASP-D117N can cause conduction disturbances in actual 
human hearts. It has been believed that cardiac conduction in 
ventricles depends on the magnitude of the available Na+ con-
ductance, which in turn depends on the voltage dependence 
of channel activation and inactivation. Computer simulations 
were performed with the Luo-Rudy phase 1 model using the 
gating kinetic parameters of the sodium channel provided in 
Table 1 (HEK-293 cells). The results demonstrated that the 
alteration of Na+ channels mediated by ZASP1-D117N would 
have a distinct effect in depolarized tissue compared with that 
by ZASP1-wt. Figure 7 shows the influence of sodium channel 
conductance and kinetics on CV. At control, CV was 57.4 cm/s. 
At 30% reduction of GNa to 11.2 mS/cm2, CV was reduced by 
≈12% to 50.5 cm/s. A right shift of 10 mV in both the activa-
tion and inactivation curves resulted in a 16% reduction to 48.1 
cm/s. The combined effect of both changes applied at the same 
time results in a reduction of 27% in CV to 41.8 cm/s.
Discussion
In this study, we demonstrated several underlying mecha-
nisms by which ZASP1-D117N, a ZASP mutation identified 
in patients suffering from dilated cardiomyopathy/LVNC, 
may cause intraventricular conduction disturbance: (1) 
ZASP1-D117N can cause loss of function of Na
v
1.5 in human 
cell lines, as well as in neonatal cardiomyocytes; (2) in silico 
simulation using the Luo-Rudy model shows that the extent 
of functional disturbances of Na
v
1.5 caused by ZASP-D117N 
is sufficient enough to delay cardiac conduction in human 
hearts; (3) the interaction between ZASP1 and Na
v
1.5 requires 
a preservation of Z-disk protein complex; and (4) the modifi-
cation of Na
v
1.5 by ZASP1-D117N occurs without significant 
disruption of Z-line structures in cardiomyocytes.
How Does ZASP1 Interact With Na
v
1.5?
In cardiomyocytes, various cytoarchitectural proteins interact 
with each other to form structural networks: (1) ZASP1 binds 
Figure 2. Western blot detects various cytoskeletal proteins 
in HEK-293 cells. Lane 1: Samples from nontransfected HEK-
293 cells; lane 2: stable HEK-293 cells expressing Flag-tagged 
Nav1.5; lane 3: stable HEK-293 cells transfected with V5-tagged 
ZASP1-wt; lane 4: stable HEK-293 cells transfected with 
V5-tagged ZASP1-D117N. Note that the staining demonstrates 
the expression of α-actinin-2 (ACTN2), dystrophin (DMD), syntro-
phin α1 (SNTA1) and ZASP previously unknown to be produced 
in HEK-293 cells.
Figure 3. ZASP1, telethonin/T-Cap, and 
Nav1.5 form a complex. A, Left gel: Posi-
tive controls using Nav1.5, ZASP1-wt, and 
ZASP1-D117N produced in Escherichia 
coli. Mid gel: Pull-down assay using HEK-
293 stable cells. Right panel: Pull-down 
assay using neonatal rat cardiomyocytes 
(NRCMs). B, Pull-down assay using ZASP 
fragments. ZM-wt indicates ZASP-wt 
 lacking the PDZ domain; ZM-D117N, 
ZASP-D117N lacking the PDZ domain.
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to ACNT2; (2) F-actin fibers are anchored to the Z-line via 
ACNT2; (3) DMD binds to F-actin,17 and (4) syntrophin α1 
forms a complex with DMD (dystrophin-associated pro-
tein complex).18 It has been reported that these proteins can 
alter the function and localization of Na
v
1.5. For example, 
dystrophin-associated protein complex can directly inter-
act with the 3 last residues of Na
v
1.5 (Ser-Ile-Val) that con-
stitutes a PDZ-binding motif and plays a role in anchoring 
Na
v
1.5 to the lateral membranes. Ablation of dystrophin can 
attenuate cardiac conduction because of a reduction in INa.18 
Figure 4. The effects of ZASP1-wt and 
ZASP1-D117N on Nav1.5 in neonatal rat 
cardiomyocytes (NRCMs). A, Superim-
posed whole-cell current traces induced 
by a step-pulse protocol from a holding 
potential of –140 mV obtained from the 
NRCM transfected with ZASP1-wt or 
ZASP1-D117N. B, I-V relationships.  
C, Voltage dependency of peak conduc-
tance and steady-state fast inactivation. 
The data were obtained and analyzed using 
same protocols and equations used in  
Figure 1. Data are presented as mean±SD.
Figure 5. Immunohistochemical analysis identifies the expression of critical cytoskeletal proteins in neonatal rat cardiomyocyte (NRCM). 
Confocal fluorescence images of NRCM were captured after transient transfection with green fluorescent protein-tagged ZASP1-wt and 
ZASP1-D117N. The NRCMs were fixed and stained with antibodies against α-actinin-2 (ACTN2), phalloidin (F-actin), dystrophin (DMD), 
syntrophin α1 (SNTA1) and telethonin/T-Cap, respectively. Scale bars, 10 μm.
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Telethonin/T-Cap, a member of Z-disk protein complex, can 
interact with Na
v
1.5, and a mutation of T-Cap can alter the 
function of Na
v
1.5.19 Recently, SAP97 was found to interact 
with Ser-Ile-Val motif of Na
v
1.5 and contribute to the localiza-
tion of Na
v
1.5 in intercalated disks.20 However, no data have 
been previously reported with regard to an interaction among 
ZASP1, telethonin/T-Cap, and Na
v
1.5.
Our study demonstrates that: (1) both wt and mutant ZASP1 
can form a protein complex with Na
v
1.5 and telethonin/T-Cap 
(Figure 3A); (2) ZASP1-D117N does not alter the associa-
tion with Na
v
1.5 and telethonin/T-Cap (Figure 3A); (3) the 
PDZ domain is necessary to form the protein complex among 
ZASP1, Na
v
1.5, and telethonin/T-Cap (Figure 3B); and (4) 
Z-line structures were not significantly disrupted by ZASP1-
D117N in cardiomyocytes (Figure 5). Therefore, we specu-
lated that the stability of Z-line structure network is important 
for interaction between ZASP1 and Na
v
1.5 and that ZASP1-
D117N might alter the function of Na
v
1.5 by affecting local 
protein conformational change. In fact, when we disbanded 
the linkage between ZASP and the cytoskeleton with ML-7 
and Cyto-D, the modulation of Na
v
1.5 by ZASP1-D117N was 
abolished. However, our study also showed that the treatment 
Figure 6. The effects of ML-7 and cytochalasin D (Cyto-D) on hNav1.5 in neonatal rat cardiomyocyte (NRCM). A, Superimposed whole-
cell current traces induced by a step-pulse protocol from a holding potential of −140 mV in the cells incubated with ML-7. B, I-V relation-
ships with ML-7 treatments. C, Voltage dependency of the peak conductance and steady-state fast inactivation. The data were obtained 
and analyzed using same protocols and equations described in Figure 1. D to F, Same protocols were performed in the cells treated with 
Cyto-D. Data are presented as mean±SD.
Table 3. Effect of ML-7 and Cytochalasin D on Nav1.5 Parameters
ML-7 Cytochalasin D
wt (n=15) D117N (n=10) wt (n=10) D117N (n=11)
Peak current density, pA/pF −231.6 (−288.4 to −193.9) −230.8 (−282.3 to −159.1) −143.8 (−219.6 to −120.2) −203.0 (−234.0 to −177.3)
Activation
 Vh, mV −36.2 (−38.7 to −35.2) −42.2 (−47.2 to −39.4) −34.8 (−35.3 to −26.9) −45.7 (−50.2 to −36.2)
 k 7.5 (5.7 to 8.3) 7.4 (6.8 to 7.8) 8.3 (7.1 to 10.4) 6.7 (6.5 to 7.4)
Fast inactivation
 Vh, mV −99.9 (−104.6 to −96.4) −95.0 (−101.7 to −91.2) −93.9 (−103.0 to −88.8) −97.9 (−106.0 to −95.1)
 k 6.8 (6.3 to 7.2)v 6.2 (5.6 to 7.1) 7.1 (5.4 to 7.7) 5.8 (5.6 to 6.6)
n indicates the number of patches; Vh, midpoint voltage of maximal activation/inactivation; k, slope factor.
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of NRCMs with ML-7 and Cyto-D did not alter INa in the cells 
transfected with ZASP1-wt. This suggests that ML-7 and 
Cyto-D may affect unknown signal transduction pathways by 
which ZASP1-D117N can cause modification of Na
v
1.5.
Another speculative underlying mechanism is that a local 
conformational change of Z-line complex by ZASP1-D117N 
may alter the mechanical stress between F-actin and DMD/syn-
trophin α1 complex, which may ultimately lead to modification 
of Na
v
1.5 function. Although we do not have a direct evidence 
of this mechanism, a similar concept has been proposed by a 
recent study using atomic force microscope that directly dem-
onstrated a critical role of telethonin/T-Cap molecule in the 
regulation of mechanical tension of cytoskeletal networks.21
Localization of Na
v
1.5 via ZASP/Telethonin Complex
Although Na
v
1.5 preferentially localizes at the intercalated 
disk via SAP97 and lateral membranes via dystrophin-asso-
ciated protein complex (2 pools), localization at the T-tubular 
system has also been recognized.22–24 It seems that Na
v
1.5 
upon posttranslational modification remains attached to the 
cytoskeleton probably linked to multiprotein complexes and 
stored in subcellular compartments. Recent study showed that 
Na
v
1.5 localizes at the cardiomyocyte membrane along the 
sarcomeric Z-lines via α-actinin-2, thus connecting Na
v
1.5 to 
actin filaments.25 ZASP/telethonin may contribute to localiz-
ing Na
v
1.5 to the T-tubular membrane at the Z-line. Therefore, 
it is unlikely that the ZASP1-Na
v
1.5-telethonin/T-Cap protein 
complex represents a new pool, but rather it brings further evi-
dence of multiprotein complex associated with α-actinin-2.
Electrical Remodeling May Precede  
Anatomic Remodeling
Our study suggests that electric remodeling may precede 
anatomic remodeling in LVNC associated with ZASP: the 
loss of function of Na
v
1.5 by the mutated ZASP1 can occur 
without significant disruption of cytoarchitectural networks. 
This is particularly important in a clinical situation because 
patients who carry ZASP1-D117N may develop arrhythmias 
even before manifesting heart failure symptoms. Although the 
conduction disturbances observed in our patients might be 
caused by degeneration or fibrosis of conduction system as a 
consequence of anatomic remodeling, it is reasonable to spec-
ulate that the loss of function of Na
v
1.5 by ZASP1-D117N 
might exaggerate the conduction delay even if it is caused by 
anatomic remodeling.
Interestingly, we have previously reported a similar obser-
vation in a cardiac-specific transgenic mouse model of dilated 
cardiomyopathy caused by p.S196L mutation in ZASP4, 
another ZASP isoform highly expressed in human hearts. In 
mice expressing ZASP4-S196L, cardiac conduction defects 
and atrioventricular block were observed at 3 months of age 
before myocardial structural remodeling, and ventricular dys-
function occurred at 10 months of age.26 In this model, we 
observed attenuation of L-type Ca2+ currents and rightward 
shift of voltage dependency of Na
v
1.5, which was different 
from electric remodeling by ZASP1-D117N.
Because we do not have multiple biopsy samples of 
patients’ cardiac muscles at different time points because of 
ethical reasons and a transgenic mouse model of ZASP1-
D117N was embryonic lethal (data not shown), we cannot 
infer whether ZASP1-D117N, also, follows the same pattern 
of ZASP4-S196L.
Can the Biophysical Modification of Na
v
1.5 by 
ZASP1-D117N Cause Conduction Blocks?
Our computer simulation demonstrated that the biophysical 
modification of INa by ZASP-D117N can reduce CV by 27%. 
However, because the actual CV in our patients was unknown, 
whether such decrease in CV can cause intraventricular con-
duction delay remains undetermined in this study. Recently, 
Smits et al27 reported that an SCN5A mutation E161K identi-
fied in a patient who suffered from overlap disease of Brugada 
syndrome and conduction block can decrease the peak INa and 
rightward shift the voltage dependency of steady-state activa-
tion, resulting in the reduction of CV in ventricle from 65 to 
50 cm/s. This suggests that a 27% reduction in CV may be 
sufficient to cause conduction disturbances, although further 
clinical electrophysiological studies are warranted.
Figure 7. Changes in conduction velocity 
(CV) in a cable of Luo-Rudy 1 model cells 
because of changes in the sodium proper-
ties. A, Measured CV as a function of GNa 
and DVact/inact (the shift in activation and 
inactivation curves). B, Standard steady-
state activation and inactivation curves 
(solid lines) and the activation and inacti-
vation curves shifted by +10 mV (dashed 
lines). C, Change in CV from the situation 
with standard parameter values (control) 
because of a reduction in the maximum 
sodium channel conductance to 11.2 
mS/cm2 (low GNa), a shift by 10 mV in the 
positive direction of the sodium channel 
activation and inactivation curves (shifted 
curves), and both of these changes (both).
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Conclusions
We conclude that ZASP1-D117N, a mutation previously 
identified in patients with cardiomyopathy, might contribute 
to conduction system diseases associated with the structural 
cardiac disease. These data confirm our previous hypothesis 
and provide novel insights into the relationship between cyto-
skeletal proteins and ion channels. Although further studies 
elucidating the detailed dynamics of wt and mutant ZASP in 
human arrhythmias and heart failure are warranted, we believe 
that our data contribute to understanding the mechanisms of 
arrhythmias in this LVNC subject and provide a new frame-
work for therapeutic interventions in patients suffering from 
arrhythmias associated with cardiomyopathy.
Study Limitation
Our system uses overexpression of ZASP1-D117N in isolated 
cells rather than using a genetically engineered mouse model. 
However, our rationale originated from the observation that 
the mRNA level of ZASP is increased in human idiopathic 
dilated cardiomyopathy,28 thus we tested whether the overex-
pression of ZASP in NRCMs might recapitulate the cytoarchi-
tectural environment in cardiomyocytes. In addition, although 
we have identified some components interacting with Na
v
1.5 
in a complex, other sodium channel components, such as 
SCN1B, SCN2B, SCN3B, and SCN4B or currently unknown 
proteins, could also be involved in the localization and regula-
tion of Na
v
1.5. Therefore, it is likely that Na
v
1.5 complex is 
much more multifaceted, and further investigation to elucidate 
these intricate connections is warranted.
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CLINICAL PERSPECTIVE
The mechanistic links between genetic cardiomyopathies and arrhythmias are not fully defined. Some patients die suddenly 
before symptomatic heart failure develops. Mutations in the Z-band alternatively spliced PDZ motif gene that encodes a 
Z-disk protein have been identified in patients with dilated cardiomyopathy, left ventricular noncompaction, and various 
cardiac arrhythmias. In the current study, we demonstrate that a Z-band alternatively spliced PDZ motif gene mutation previ-
ously identified in left ventricular noncompaction patients can cause loss of function of the cardiac sodium channel. Z-band 
alternatively spliced PDZ motif gene forms a protein complex with telethonin, a member of Z-disk proteins, and Na
v
1.5. The 
proper function of this complex, including its interaction with actin fibers, may play an important role in the regulation of 
cardiac ion channels. This suggests a mechanism by which a mutation that disrupts a structural protein causes electrophysi-
ological remodeling that may contribute to arrhythmias as an early manifestation of these cardiomyopathies.
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1 
SUPPLEMENTAL MATERIAL 
Expanded Methods 
Cell preparation and transient expression of wt and mutant ZASP1  
Wt and mutant ZASP1 were generated as previous described.1 Cell preparation and transient 
transfection were performed as previously described.  Sarcomere disturbances were carried out 
by the incubation of HEK-293 cells for 30 minutes in the medium containing 30 μM ML-7 
(Sigma-Aldrich, MO) or Cytochalasin D (Cyto-D, Sigma-Aldrich, MO). The effects of wt and 
mutant ZASP1 on IK were studied in CHO cells which stably expressed KCNQ1 and KCNE1, or 
KCNH2 and KCNE2 with transient expression of ZASP1-wt or ZASP1-D117N. 
 
Neonatal rat cardiomyocyte (NRCM) isolation and transient expression of wt and mutant 
ZASP1 
All procedures were approved by the Institutional Animal Care and Use Committee at the 
Texas Heart Institute. The neonatal rat cardiomyocytes were isolated according to the procedure 
as previously described.10 Briefly, neonates (<3 days after birth) were deeply anesthetized with 
pentobarbiturate (i.p.). The hearts were excised quickly and rinsed in ice-cold PBS (Dulbecco’s 
phosphate-buffered saline, Invitrogen, Carlsbad, CA). The ventricles were transferred to a dry 
Petri dish and minced with a scalpel blade. The minced hearts were digested in a warm 
collagenase II and procaine. The digested cells were resuspended in adhesion medium: DMEM 
(ATCC, Manassas, VA) supplemented with 10% FBS and 2 mM glutamate. The cells were 
2 
placed on a 100 mm Petri dish and incubated for 1-1.5 hours at 37˚C with 5% CO2. After 
fibroblasts were settled and stick to the bottom of the dish, the supernatants were collected. 
Cardiomyocytes (1-2 millions) were aliquot into a 1.5 ml Eppendorf tube and centrifuged. The 
cells were resuspended in a transfection buffer (VPE-1002, Amaxa, Gaithersburg, MD) with 10 
µg plasmid pcDNA3.1-CT-GFP-TOPO containing either ZASP1-wt or ZASP1-D117N cDNA 
and transferred into cuvettes. The transfection (nucleofection) was performed with an 
electroporator according to the company’s protocol (Nucleofector-I Amaxa, Gaithersburg, MD). 
The cells were incubated for 24 hours at 37˚C with 5% CO2. The cells showing green 
fluorescence were selected to recode sodium currents (INa).  
 
Patch-clamp  
Experiments were carried out at ambient temperature unless otherwise stated. For INa 
recording, the pipette solution contained (in mM): 5 NaF, 115 CsF, 20 CsCl, 10 EGTA and 10 
HEPES (pH 7.35 with CsOH), and the bath solution contained (in mM): 145 NaCl, 1.0 MgCl2, 
10 tetraethylammonium (TEA) chloride, 5 CsCl, 10 HEPES, and 10 glucose (pH 7.35 with 
NaOH). Whole-cell currents amplitude and gating kinetics were analyzed with Clampfit (Axon 
Instruments, Sunnyvale, CA) and Igor software (WaveMetrics, Lake Oswego, OR).  
 
Immunohistochemistry 
 Following antibodies were used: (1) mouse monoclonal anti-telethonin/T-Cap (1:100, 
3 
Sigma-Aldrich); (2) mouse monoclonal anti-ACTN2 (1:200); (3) rabbit polyclonal anti- 
dystrophin (DMD, 1:200); and (4) rabbit polyclonal anti- α1-syntrophin (SNTA1, 1:200). F-actin 
was labeled with fluorescent phalloidin (1:500, Invitrogen). The nucleus was labeled with To-pro 
633 nm (Invitrogen).  
 
In vitro interaction pull-down assay 
To produce ZASP and Nav1.5, E. coli were transformed with pcDNA 3.1/V5-His containing 
ZASP1-wt or ZASP1-D117N, and SCN5A. The purified ZASP1-wt (His) or ZASP1-D117N (His) 
was incubated with preys: the purified Nav1.5 from HEK-293 cells, and the lysate from NRCMs. 
The eluted proteins were separated by SDS–PAGE, and stained with anti-pan voltage-gated 
sodium channel (1:100), anti-telethonin (1:100), and anti-α-actinin antibodies (1:100). The 
pcDNA3.1/V5-His-TOPO/lacZ (Invitrogen, Carlsbad, CA) was used for negative controls.  
 
 
 
 
 
 
 
 
4 
Supplemental Experiments 
 
 
 
 
 
 
 
Supplemental Figure S-I. Effects of ZASP1-wt and ZAP1-D117N on the late INa. 
(A) Representative traces of late INa (INa,L) obtained from the cells stably expressing Nav1.5 
transfected with ZASP-wt or ZASP-D117N. INa,L was induced with a long depolarization pulse (-
30 mV for 1000 ms from a holding potential of -80 mV). (B) Bar graph demonstrates the 
normalized amplitudes of INa,L obtained from the cells transfected with ZASP1-wt or ZASP1-
D117N. INa,L were measured at 200 to 220 ms of the test pulse, and normalized by the peak INa. 
The numbers in the parenthesis depict the number of cells studied. The error bars represent SD. 
 
 
 
 
 
 
 
5 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Figure S-II. Effects of different ratios of ZASP1-wt and ZASP1-D117N 
plasmids on Nav1.5. (A) The I-V relationships of peak INa obtained from the cells transfected 
with various combinations of ZASP1-wt and ZASP1-D117N plasmids: 1 µg/5 µg; 3 µg/3 µg; 5 
µg/1 µg. (B) The bar graphs of peak INa for each condition. The numbers in the parenthesis 
depict the number of cells studied. The error bars represent SD. *p<0.05 vs. 5 µg/1 µg.  
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Effects of ZASP1-D117N on delayed rectifier potassium channels 
Since abnormal repolarization may also cause cardiac conduction disturbances, we sought to 
investigate whether ZASP1-D117N can affect the function of two major components of delayed 
rectifier potassium channels (the slow component, IKs and the rapid component, IKr). The 
experiments were conducted in the CHO cells stably-transfected with KCNQ1 with KCNE1 or 
KCNH2 with KCNE2, which mimics IKs and IKs, respectively. Supplemental Figure S-III 
showed that the steady-state peak IKs (Panel A) and IKr (Panel C) were not significantly affected 
by ZASP1-D117N. The I-V relationships of the steady-state IKs (Panel B) and IKr (Panel D) were 
almost identical between the cells expressing ZASP1-D117N and ZASP1-wt. These results 
indicate that ZASP1-D117N specifically altered the Nav1.5 functions. Supplemental Table S-I 
summarizes the parameters. 
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Supplemental Figure S-III. The effect of ZASP1-wt and ZASP1-D117N on slow delayed 
rectify potassium currents (IKs) and rapid delayed rectifier current (IKr). (A) Representative 
current traces of IKs. (B) Current-voltage (I-V) relationship of IKs activation. The current 
amplitude was measured at the end of five second pulse between -60 mV and 60 mV from a 
holding potential of -80 mV. (C) Representative current traces of IKr. (D) I-V relationship of IKr 
activation. The current amplitude was measured at the end of second pulse between -60mV and 
60 mV from a holding potential of -80 mV.  
 
Table S-I. Parameters of K+ channels 
 IKs  IKr  
 WT (n=15) D117N (n=11) WT (n=10) D117N (n=9) 
Peak current 
density (pA/pF)  
40.6 [36.5; 47.2] 
(at 60mV) 
35.2 [33.8; 41.3]  
(at 60mV) 
2.4 [1.0; 3.3]     
(at 0mV) 
3.2 [0.5; 5.7]     
(at 0mV) 
Tail current 
density at 
(pA/pF) 
-15.0 [-24.0; -11.7] 
(at -40mV) 
-12.1 [-35.9; -6.7]  
(at -40mV) 
2.7 [0.4; 4.2]     
(at -40mV) 
3.6 [1.4; 5.5] 
(at -40mV) 
Data are presented as median [25th percentile; 75th percentile]. 
 
